< Back to scientific publications

Magazine 9.54

Brivaracetam as add-on treatment in patients with post-stroke epilepsy: real-world data from the BRIVAracetam add-on First ItalianųoRk Study (BRIVAFIRST).

Authors: Lattanzi S, Canafoglia L, Canevini MP, Casciato S, Irelli EC, Chiesa V, Dainese F, De Maria G, Didato G, Gennaro GD, Falcicchio G, Fanella M, Ferlazzo E, Gangitano M, La Neve A, Mecarelli O, Montalenti E, Morano A, Piazza F, Pizzanelli C, Pulitano P, Ranzato F, Rosati E, Tassi L, Di Bonaventura C; BRIVAFIRST Group Membership

Date: 2022

Scope of interest: Epilepsy




You may also be interested in:

Magazine

The efficacy of Choep chemotherapy regimen administered in association with monoclonalantibody anti-CD52 Alemtuzumab in cutaneous T-celllymphoma (CTCL) and systemic T-celllymphoma with cutaneous involvement (PTCL)

Authors: Postorino M, De Santis G, Marchesi F, Provenzano I, Franceschini L, Pupo L, Rizzo M, Giannì L, Gumenyuk S, Tonialini L, Fiorelli E, Renzi D, Zizzari A.

Date: 2013

Scope of interest: Haematology


Read details
Report/Poster of Convention/Congress Act

Programmed Motor Activity with Cognitive Stimulation is associated with cognitive stability in Alzheimer’s disease

Authors: A.M. Abbatecola, C. Di Meo, M. Gemmiti, M. Russo (Frosinone, Cassino)

Date: 2019

Scope of interest: Motor Activity, Dementia


Read details
Report/Poster of Convention/Congress Act

Intravenous use and efficacy of ferric carboxymaltose (FERINJECT) in patients with iron deficiency anemia at the SIMT of Frosinone

Authors: Giorgia Guiducci (1) - Deborah Ilaria Gadaleta (1) - Maria Chiara De Nicolò (1) - Francesca Docimo (1) - Anna Maria Galuppi (1) - Alba Amengoni (1) - Rosaria D’Emilio (1) - Manuela Alò(1) - Lucia Capoccetta (1) - Manuela Gibellini(1) - Elena Gigliotti (1) - Carla Gargiulo

Date: 2020

Scope of interest: Clinical pathology


Read details